Active pharmaceutical ingredients under development
Product Name
CAS Number
Specification
TP
DMF
Status
Seladelpar
851528-79-5
Q3 2026
Q2 2027
Selumetinib
606143-52-6
Q3 2025
Q1 2026
Tepotinib
1100598-32-0
Q4 2025
Q2 2026
Tezacaftor
1152311-62-0
Q3 2025
Q1 2026
Tofogliflozin
1201913-82-7
Q4 2025
Q2 2026
Tovorafenib
1096708-71-2
Q4 2025
Q2 2026
Tucatinib
937263-43-9
Q3 2025
Q1 2026
Upadacitinib
1310726-60-3
Q3 2025
Q1 2026
Vanzacaftor
2374124-49-7
Q4 2025
Q2 2026
Venetoclax
1257044-40-8
Q3 2025
Q1 2026
Zavegepant
1337918-83-8
Q1 2026
Q3 2026